Wednesday, January 14, 2026

Cognetivity To Study Use Of Cognitive Tool To Detect Concussions From Sports

Cognetivity Neuroscience (CSE: CGN) is looking to expand the scope of its cognitive testing platform. The company this morning announced that it will be undertaking a new study with Durham University, as well as My Sports Wellbeing.

Collectively, the three groups are to work together to determine the ability of the firms cognitive testing platform to detect changes in cognitive health as a result of concussions, specifically as they relate to high impact sports. The tool will be tested for the ability of detecting concussions, as well as any changes to cognitive function as a result of repeated sub concussions.

The study is to primarily focus on concussions developed as a resulting of playing rugby, as well as other community sports. It’s currently estimated that as much as 89% of concussions are either missed or misdiagnosed currently, resulting in ineffective or inappropriate medical care.

Associate Professor Karen Hind at Durham University is to take a central role in the study. Notably, she lead the first independent study on the health of retired rugby players, and is currently researching short and long term risks from injury from sports.

“We’re very excited to be working on this study. Cognetivity’s unique technology represents a promising way to assess cognitive health in athletes at risk of concussion, post concussion and in relation to sub-concussions. This study is part of our overall programme of research through which we seek to investigate and provide strategies to improve athlete health and welfare,” said Dr Hind.

Cognetivity Neurosciences last traded at $0.355 on the CSE.


FULL DISCLOSURE: Cognetivity Neurosciences Ltd is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Cognetivity Neurosciences Ltd on The Deep Dive, with The Deep Dive having full editorial control. We may buy or sell securities in the company at any time. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Why Silver Needs to Slow Down to Go Higher | Dan Dickson – Endeavour Silver

Silver Dips Are Getting Bought, This Is How Breakouts Start | John Feneck

Why $100 Silver Right Now Would Be a Problem | Keith Neumeyer – First Majestic

Recommended

Antimony Resources Planning 10,000 Metre Drill Program For H1 2026

Canadian Copper Closes On Sale Of Turgeon Project In New Brunswick For Cash And Shares

Related News

Cognetivity Reaches First Commercial Agreement In Middle East

Cognetivity Neurosciences (CSE: CGN) has seen the deployment of its technology to a new region...

Wednesday, September 22, 2021, 09:41:33 AM

Cognetivity Neurosciences Files Patent For System Capable Of Early Detection Of Alzheimer’s Disease

Cognetivity Neurosciences (CSE: CGN) this morning announced that it has filed for a key new...

Tuesday, June 8, 2021, 10:08:19 AM

Cognetivity’s Assessment Tool To Be Deployed At KetamineOne Clinics Across North America

Cognetivity Neurosciences (CSE: CGN) will soon see its cognitive assessment tool for the early detection...

Wednesday, September 1, 2021, 08:22:59 AM

Cognetivity Neurosciences Sees Granting Of FDA Clearance For Cognitive Assessment Tool

Cognetivity Neurosciences (CSE: CGN) has reached a major achievement. The company has been granted FDA...

Wednesday, October 20, 2021, 09:22:23 AM

Cognetivity Neurosciences: Echelon Initiates Coverage With $0.85 Price Target

On Friday, Echelon Capital Markets initiated coverage on Cognetivity Neurosciences (CSE: CGN) with a speculative...

Monday, April 19, 2021, 10:36:00 AM